medicare semaglutide drug price negotiations: Study predicts drugs up next Biden Proposes Coverage of Obesity

Many chose to ignore them because the prices were right

Conclusions To summarize, this secondary analysis of a randomized clinical trial examined changes in site-specific BMD during diet-induced weight loss followed by a 1-year intervention with liraglutide (3.0 mg/day), exercise, or their combination, compared to placebo

11.6 Evidence-Based Position Based on current literature: GLP-1 receptor agonists do not inherently cause universal nutrient depletion Intake-related vulnerability is plausible and patient-dependent Long-term micronutrient data remain limited Risk increases with magnitude and duration of weight loss Structured dietary strategy is protective Weight loss pharmacotherapy should be paired with nutritional planning

Lack of effect of oral sulforaphane administration on NRF2 expression in COPD: a randomized, double-blind, placebo-controlled trial